相关实验视频

Updated: May 5, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

一个基于微阵列的IgE-分子模拟指数 (IgE-MMI):一种疾病严重程度,临床表型和治疗反应的生物标志物在亚托邦性皮炎?

Enrico Scala¹, Stefania Madonna¹, Damiano Abeni¹

¹Fondazione Luigi Maria Monti, IDI-IRCCS, Rome, Italy.

|November 4, 2024

概括

对人类同源的外源分子过敏原 (HEMA) 的IgE反应与严重的亚托皮炎 (AD) 有关. 一个新的IgE分子模拟指数 (IgE-MMI) 可以预测AD严重程度和dupilumab治疗结果.

科学领域:

免疫学免疫学免疫学
皮肤病学皮肤病学
过敏研究研究过敏

背景情况:

免疫球蛋白E (IgE) 在阿托皮性皮炎 (AD) 中的作用受到争议,特别是IgE对人类同源外源分子过敏原 (HEMA) 的反应.
了解对HEMA的IgE反应性对于推进AD研究和治疗策略至关重要.

研究的目的:

调查IgE抗体对HEMA和AD的反应之间的关联.
为了确定这些反应是否与AD严重程度和患者对dupilumab治疗的反应相关.

主要方法:

用IgE微阵列测量了3325名参与者的血清IgE抗体对183种过敏原分子.
一个"IgE分子模拟指数" (IgE-MMI) 是基于对五个HEMA蛋白家族的反应性而开发的.
后勤回归分析了IgE与HEMA,IgE-MMI,AD,严重程度和dupilumab反应之间的关联.

主要成果:

与非HEMA (2.2%) 相比,严重的AD患者 (67%) 的IgE对HEMA的敏感性明显更为普遍.
IgE-MMI显示与AD严重程度的阳性增加 (10.7%在没有AD的过敏患者中,到54%的严重AD患者中).
特定的表型和较差的dupilumab反应与IgE对某些HEMA的反应性有关 (例如,ENO,MnSOD).

结论:

IgE微阵列有效地评估了过敏患者对HEMA的IgE反应性.
对HEMA的IgE反应和阳性IgE-MMI可能作为严重AD,其表型和dupilumab反应的生物标志物.

关键词:

在 IgE 中,IgE 是亚托邦性皮肤炎的发生.自动活动性自动活动性.宏观数组宏观数组是一个宏观数组.分子仿真是分子仿真.

更多相关视频

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Allergic Reactions: Anaphylaxis

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...

Acute Inflammation I: Inflammatory Response

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect...